Hypoglycemic effect of aqueous leaf extracts of Vernonia amygdalina and Ficus exasperata following separate and concurrent administrations

Main Article Content

Zainab M. Shanu
Adebusuyi A. Ademisoye
Julius O. Soyinka

Abstract

Background: Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia due to either insufficient insulin production or insulin resistance. The increasing global prevalence of diabetes necessitates the need to explore alternative treatment options. Vernonia amygdalina and Ficus exasperata are widely used traditional herbal remedies with potential antidiabetic properties. This study aimed to assess the effects of these plants, both individually and in combination, on blood glucose levels in normoglycemic individuals following glucose-induced hyperglycemia.


Objectives: This study evaluated the glucose-lowering effects of aqueous extracts of Vernonia amygdalina and Ficus exasperata, both separately and in combination, in normoglycemic individuals, comparing their efficacy to that of the standard drug, Glimepiride.


Methods: Participants were randomly assigned to four groups. Group A (n=5) served as the standard and received 2 mg of Glimepiride. Groups B (n=10), C (n=10), and D (n=10) were administered varying dosages of Vernonia amygdalina, Ficus exasperata, or a combination of both, respectively. Specifically, within each group Subgroup B1 (n=5) received 200 mg/kg of V. amygdalina, and Subgroup B2 (n=5) received 400 mg/kg. Subgroup C1 (n=5) received 200 mg/kg of F. exasperata, while Subgroup C2 (n=5) received 400 mg/kg. Subgroups D1 and D2 were given a combination of both extracts at 200 mg/kg and 400 mg/kg, respectively. Blood glucose levels were measured at baseline, 30 minutes post-glucose ingestion (0.5 hour), and 1, 2, and 4 hours post-treatment. Data were analyzed using repeated one-way ANOVA followed by Bonferroni post-hoc comparisons to assess the statistical significance of the glucose-lowering effects.


Results: Vernonia amygdalina at 200 mg/kg significantly (p<0.05) reduced blood glucose levels at 2 hours and 4 hours post-treatment. The 400 mg/kg dose exhibited a more potent and sustained effect, with significant reductions at all time points. Ficus exasperata at both 200 mg/kg and 400 mg/kg also showed significant hypoglycemic effects, with the 400 mg/kg concentration being more effective. The combination of both extracts produced moderate to strong hypoglycemic effects, particularly at the 400 mg/kg dose, with significant (p<0.05) reductions observed at all time points. Glimepiride consistently resulted in significant (p<0.05) glucose reductions at all intervals, outperforming the herbal extracts.


Conclusion: Both Vernonia amygdalina and Ficus exasperata, individually and in combination, exhibit potent glucose-lowering effects. Their efficacy, especially at higher doses, is comparable to Glimepiride, suggesting their potential as alternative or complementary treatments for managing blood glucose levels in diabetes.

Downloads

Download data is not yet available.

Article Details

How to Cite
Shanu, Z. M., Ademisoye, A. A., & Soyinka, J. O. (2024). Hypoglycemic effect of aqueous leaf extracts of Vernonia amygdalina and Ficus exasperata following separate and concurrent administrations. West African Journal of Pharmacy, 35(2), 78-91. https://doi.org/10.60787/wajp.vol35no2.357
Section
Articles
Author Biography

Julius O. Soyinka, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.

Telephone: +234 803 582 2785

How to Cite

Shanu, Z. M., Ademisoye, A. A., & Soyinka, J. O. (2024). Hypoglycemic effect of aqueous leaf extracts of Vernonia amygdalina and Ficus exasperata following separate and concurrent administrations. West African Journal of Pharmacy, 35(2), 78-91. https://doi.org/10.60787/wajp.vol35no2.357

Share

References

1. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. (2021) Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinology. 9:174-88. 10.1016/S2213-8587(20)30381-8

2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes Atlas, 9(th) edition. Diabetes Research Clinical Practice. 157:107843.

3. Ayoola MD, Ogundeko YB, Obanleowo TD, Omole DO, Chukwu BN, Faloye KO. (2024). Evaluation of the Antidiabetic Activities of the Fruit of Parquetina nigrescens (Afzel.) Bullock and In Silico Identification of Its Antidiabetic Agent. Bioinformatics Biology Insights. 26:11779322231223857. doi: 10.1177/11779322231223857.

4. Xie F, Chan JC, Ma RC. (2018). Precision medicine in diabetes prevention, classification and management. Journal Diabetes Investigation. 9:998-1015.

5. Iqbal A, Heller SR. (2018) The role of structured education in the management of hypoglycaemia. Diabetologia. 61:751-60. 10.1007/s00125-017-4334-z

6. Yun JS, Ko SH. (2021) Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism. 123: 154838. 10.1016/j.metabol.2021.154838

7. Altaf Dar M, & Zulfkar Qadrie. (2024). Diabetes Mellitus and Diverse Approaches to Its Management in Practical Application. South East Asia Journal of Medical Sciences, 8(1), 1-14.

8. Jayaweera U, Akowuah GA, Ling, CY, Kumar PV & Herapathdeniya S. (2022). Diabetes and Vernonia amygdalina Delile (Asteraceae). Biointerface Research in Applied Chemistry, 12(4), 4496-4517. https://doi.org/10.33263/BRIAC124.44964517.

9. Ogbuagu Emmanuel O, Airaodion Augustine I, Ogbuagu Uloaku and Airaodion Edith O., (2019). Effect of Methanolic Extract of Vernonia amygdalina Leaves on Glycemic and Lipidaemic Indexes of Wistar Rats DOI: 10.9734/AJRIMPS/2019/v7i330122.

10. Asante DB, Wiafe GA. (2023). Therapeutic Benefit of Vernonia amygdalina in the Treatment of Diabetes and Its Associated Complications in Preclinical Studies. Journal Diabetes Research. 22:3159352.

11. IfedibaluChukwu EI, Aparoop D, Kamaruz Z., (2020). Antidiabetic, anthelmintic and antioxidation properties of novel and new phytocompounds isolated from the methanolic stem-bark of Vernonia amygdalina Delile (Asteraceae). Scientific African 10. doi:10.1016/j.sciaf.2020.e00578.

12. Adetuyi BO, Adebisi OA, Adetuyi OA, Ogunlana OO, Toloyai PE, Egbuna C, Uche CZ, Khan J, Adumanya OCU, Patrick-Iwuanyanwu KC. (2022) Ficus exasperata Attenuates AcetaminophenInduced Hepatic Damage via NF-κB Signaling Mechanism in Experimental Rat Model. Biomedical Research International. 24: 6032511. doi: 10.1155/2022/6032511.

13. Wahua C, Odogwu B, Ukomadu J. (2021). Macroand Micro-Morphological Characteristics and Phytochemical Constituents of Ficus exasperata Vahl. of Moraceae. Scholars Academic Journal of Biosciences. 9. 111-115. 10.36347/sajb.2021.v09i04.002.

14. Soji-Omoniwa, Omolola & Oloyede, Hussein. (2016). Effect of Ficus exasperata Leaf-Based Diet on Antioxidant Parameters of Type 2 diabetic Rats. 10.19240/njpas.2016.A33.

15. Akoko, Sokiprim & Aleme, Benjamin & Uahomo, Precious. (2022). The Effect of Addition of Extracts of Vernonia amygdalina and Moringa oleifera in the Nutrition of Alloxan- Induced Diabetic Wistar Rats. 10. 3455-3462. 10.21276/ijprhs.2022.04.04.

16. Jude, AI., Keneolisa, AF., Ogbonna, OR., Maduabuchi, OR., & Ugochukwu, NE. (2022). Evaluation of Anti-Diabetic Property of Methanol Extract of Ficus exasperata Vahl. (Moraceae). Advances in Research, 23(5),44-49.

17. Jimoh-Abdulghaffaar HO, Ajibare AJ, Akintoye OO, Jimoh OS, Ananias EN, Owoyemi JO, Ibiyeye VO, Ojulari LS. (2023) Ficus exasperata leaves aqueous extract influences pathophysiolgicm mechanisms of diabetic peripheral neuropathy in a rat model. Journal Applied Pharmaceutical Sciences, 13(09):77-83.

18. Talwar A, Chakraborty N, Zahera M, Anand S, Ahmad I, Siddiqui S, Nayyar A, Haque A., & Saeed, M. (2024). Antidiabetic potential of phytochemicals found in Vernonia amygdalina. Journal of Chemistry, 6(11) 3-12

Similar Articles

You may also start an advanced similarity search for this article.